IMPACT OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION ON DIABETES RELATED COMPLICATIONS AND ASSOCIATED COSTS IN TYPE 2 DIABETES PATIENTS IN FINLAND

被引：0
|
作者：
Roze, S. [1 ]
Delbaere, A. [2 ]
de Portu, S. [2 ]
Bjornstrom, K. [3 ]
Honkasalo, M. [4 ]
机构：
[1] Heva Heor Sarl, Hlth Econ, Lyon, France
[2] Medtron Int Sarl, Diabet, Tolochenaz, Switzerland
[3] Medtronic, Medtron Finland, Vantaa, Finland
[4] Nurmijarvi Hlth Ctr, Diabetol Ward, Nurmijarvi, Finland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
057
引用
收藏
页码：A27 / A28
页数：2
相关论文
共 50 条
  • [21] Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
    Feng-fei Li
    Bing-li Liu
    Guo-ping Yin
    Reng-na Yan
    Dan-feng Zhang
    Jin-dan Wu
    Lei Ye
    Xiao-fei Su
    Jian-hua Ma
    Scientific Reports, 8
  • [22] Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
    Li, Feng-fei
    Liu, Bing-li
    Yin, Guo-ping
    Yan, Reng-na
    Zhang, Dan-feng
    Wu, Jin-dan
    Ye, Lei
    Su, Xiao-fei
    Ma, Jian-hua
    SCIENTIFIC REPORTS, 2018, 8
  • [23] ABC OF DIABETES - CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    PICKUP, JC
    BRITISH MEDICAL JOURNAL, 1982, 285 (6334): : 49 - 50
  • [24] Insulin glulisine for continuous subcutaneous insulin infusion in pediatric type 1 diabetes
    Urakami, Tatsuhiko
    Mine, Yusuke
    Aoki, Masako
    Okuno, Misako
    Suzuki, Junichi
    PEDIATRICS INTERNATIONAL, 2017, 59 (05) : 647 - 649
  • [25] Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion
    Moyes, V
    Driver, R
    Croom, A
    Mirakian, R
    Chowdhury, TA
    DIABETIC MEDICINE, 2006, 23 (02) : 204 - 206
  • [26] Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutaneous insulin infusion
    Moyes, V
    Driver, R
    Mirakian, R
    Chowdhury, T
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (10): : 1417 - 1417
  • [27] Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes
    Tamborlane, William V.
    Sikes, Kristin A.
    Steffen, Amy T.
    Weinzimer, Stuart A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 : S112 - S115
  • [28] Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
    Lyu, Fu-ping
    Huang, Bing-kun
    Su, Wei-juan
    Yan, Fang-fang
    Zeng, Jin-yang
    Chen, Zheng
    Zhang, Yu-xian
    Wang, Shun-hua
    Huang, Yin-xiang
    Zhang, Mu-lin
    Shi, Xiu-lin
    Lin, Ming-zhu
    Li, Xue-jun
    DIABETES THERAPY, 2020, 11 (03) : 701 - 710
  • [29] TREATMENT OF TYPE-I DIABETES BY CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    VANBALLEGOOIE, E
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (04) : 171 - 172
  • [30] Factors Associated with Adherence to Continuous Subcutaneous Insulin Infusion in Pediatric Diabetes
    Babar, Ghufran S.
    Ali, Omar
    Parton, Elaine A.
    Hoffmann, Raymond G.
    Alemzadeh, Ramin
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (03) : 131 - 137
12345